According to the company, H1 net sales growth was driven by continued global demand for key medicines, including JARDIANCE, a ...

However, yesterday GSK announced that the FDA has extended the review period for Blenrep to give the agency time to review ...

Back in May, health data company Datavant announced its plans to acquire Aetion, creating a formidable player in the ...

This pricing shock immediately exposed pharma’s second crisis: R&D costs that continue to climb, now between $0.8 and $2.8 ...

Alexion, the rare disease unit acquired by AstraZeneca nearly five years ago, has announced high-level positive results from ...

In a sector where trust is critical, and attention is limited, that feeling matters. Frictionless design isn’t just about ...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...

The Evolution Summit is designed to address the most pressing challenges and opportunities in clinical trials, with a focus ...

Agentic AI refers to AI systems that add layers of reason and autonomy. They act as largely independent agents that are ...

Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous ...

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has formally signed off on a recommendation to remove ...

The 3rd Spatial Biology for Drug Development Summit is your opportunity to come together with leading biopharma experts to ...